GL US S&P 500Russell 1000 Earnings call · transcribed from the recording
Globe Life (GL) · Q3 2026 results and valuation
Share price: $161.80 · 2026-11-11
Globe Life is an insurance holding company that provides life and supplemental health insurance products. It serves individual consumers, working families, and Medicare beneficiaries through direct-to-consumer channels and various agent networks in the United States, Canada, and New Zealand. Source: 10-K annual report (2026-02-25)
Results Q3 2026 vs Q2 2026 · previous quarter · published 21 Oct 2026 and 23 Jul 2026
Management sounded restrained, in its script and in answers to analysts.
1 · Numbers
—
No financial figures for this pair
Outlook given
2 · How management spoke
Restrained
Less upbeat than 68% of company calls
Answers to analysts: typical, in line with the script.
Similar to last call.
3 · What stood out
Figure
Globe Life's fixed maturity investment portfolio has a net unrealized loss position of $2.7 billion dollars due to the current market rates being…
Valuation
Is Globe Life undervalued?
Reverse DCF on net income from the last full fiscal year (no meaningful free cash flow: a bank, insurer or a year of negative cash flow) (2025-12-31), grown for 10 years, discounted back, plus a terminal value. “Implied growth” is the rate the current price assumes.
At 4.7% growth a year (3-year revenue growth), the model's fair value is $241.89 a share — the stock trades 33% below it. Today's price assumes −0.9% growth a year.
Current price
$161.80
close of 2026-11-11
Market implies growth of iThe yearly free-cash-flow growth, for the next 10 years, that today’s share price already assumes. If you believe the company grows faster than this, the stock is cheap under this model; slower, and it is expensive.
-0.9% for 10 yrs
Fair value / share
$241.89
Buy below
$181.42
Price vs fair value
Undervalued 33%
Price vs buy-below price
Undervalued 11%
Management expects
Revenue +2.5% · from the Q3 2026 report: “🔥 "For the full year, we expect life premium revenue to grow between 2.5% and 2.75%, driven by strong premium growth in our American income and Liberty…”
A guidance figure for revenue, usually one year ahead, not a 10-year free-cash-flow rate.
Read between the lines
-
Guidance
For the full year, Globe Life expects life premium revenue to grow between 2.5% and 2.75%, driven by strong premium growth in its American income and Liberty National divisions.
-
Guidance
At the midpoint of its guidance, Globe Life anticipates total premium revenue growth of 6% to 8% for the full year, with life premium revenue growth of 2% to 4% and health premium revenue growth of 13% to 15%.
-
Figure
In health insurance, premium revenue grew 16% to $447 million and health underwriting margin was up 7% to $116 million.
-
Figure
Net health sales were $48 million, a 95% increase over the year-ago quarter.
-
Guidance
For the full year, Globe Life expects net investment income to grow around 4.5% and required interest to grow around 3.5%, resulting in excess investment income growth of 10% to 11%.
4 more
-
Guidance
Globe Life expects the average yield earned on its total long-term investments will be approximately 5.51% for the full year 2026, and between 5.5% and 5.55% for the full year 2027.
-
Figure
Anticipate share repurchases will be in the range of $725 million to $775 million, with.
-
Guidance
For the full year 2026, Globe Life estimates net operating earnings for diluted share will be in the range of $15.35 to $15.65, a decrease from the prior guidance reflecting the impact of third quarter results and revisions to fourth quarter margin estimates for United American.
-
Key theme
As Globe Life mentioned on the last call, it believes that expanding AI use across the company will allow us, over time, to grow its expenses at a rate lower than its revenue growth given the high transaction volumes inherent in its business.
Tone
How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q3 2026. Ring: Q2 2026.
Script and answers carried a similar tone, so the script's message held up under questioning.
Sentences that drove the tone
“For the full year, 2027, we expect mid- to high-single-digit sales growth, and I'm confident that we will increase sales growth for this division as the fundamental conditions necessary for...”
“The strong premium growth is due to premium rate increases on our Medicare supplement business, as well as strong sales in both our United American and Family Heritage divisions.”
“And I continue to be pleased with the aging count growth, and I'm confident that this will drive strong sales growth going forward.”
Full figures
USD · SEC EDGAR XBRL (10-Q, period end 2026-06-30)
| Metric | Q3 2026not yet filed | Q2 2026period end 2026-06-30 | Change | Q3 2025 | YoY |
|---|---|---|---|---|---|
| Revenue | — | 1.60B | 1.51B | ||
| Operating income | — | 354.9M | 477.1M | ||
| Net income | — | 287.7M | 387.8M | ||
| EPS | — | 3.65 | 4.73 | ||
| P/E today 10.5 | — | 11.9 | — | 10.4 | — |
Topics
Most discussed now
- The average producing agent count for the third quarter was $11,331, which was essentially flat compared to the second quarter...
- Absent a large decline in assumption update, Liberty's life underwriting margin would have been up 5%, and net life sales...
- Joining the call today are Frank Savota and Matt Darden, Globe Life's co-chief executive officers, Tom Kombach, its chief financial…
- As was the case in 2025, Globe Life recorded a re-measurement gain related to assumption updates this quarter, reflecting its positive...
- If anything, the current economic environment enhances Globe Life's value proposition to individuals looking for a better opportunity.
Faded since Q2 2026
- Fading For the full year, Globe Life expects total premium revenue growth to be in the range of 6.5% to 7%.
- Fading As clearly demonstrated by Globe Life having produced double digit net operating income per share growth in 8 of the...
- Fading As a reminder, compensation adjustments designed to improve agent recruiting new agent retention were implemented at the beginning of the...
- Fading In the second quarter, the earned yield on Globe Life's total long term invested assets which include its fixed maturity, commercial...
Latest announcements
Official filings, newest first. Summaries are generated from each filing and its attachment; every figure is checked against the source.
- Articles or bylaws amended · SEC 8-K · routine
- Results of operations · SEC 8-K
Globe Life reported net income of $4.62 per diluted common share for the third quarter of 2026, compared to $4.73 in the same period of the previous year.
- Director or officer change · SEC 8-K
David A. Rodriguez retired from the Board of Directors of Globe Life Inc. on August 4, 2026, for personal reasons.
- Results of operations · SEC 8-K
Globe Life reported net income of $3.65 per diluted common share for the second quarter of 2026, compared to $3.05 for the same period in 2025.
- Material agreement · SEC 8-K
- Director or officer change; Shareholder vote results · SEC 8-K
Shareholders voted on the election of directors, the 2025 executive compensation, the 2026 incentive plan, and the ratification of Deloitte & Touche LLP as independent auditor.
- Results of operations · SEC 8-K
Globe Life reported net income of $3.39 per diluted common share for the first quarter of 2026, compared to $3.01 per diluted common share in the same period of the previous year.
- Director or officer change · SEC 8-K
Balance sheet & ownership
From SEC filings; short interest is FINRA data via Yahoo. Collected 2026-11-08.
Cash & runway
Cash & equivalents
$38.8M
2013-09-30
Short-term investments
$95.2M
total $134.0M
Implied runway
—
operating cash flow positive over the TTM window
Dilution
weighted-average basic shares, per quarter. Change: -5.1% YoY, -1.1% QoQ.
| Quarter | Shares |
|---|---|
| Q1 2025 | 83.5M |
| Q2 2025 | 81.9M |
| Q3 2025 | 80.7M |
| Q1 2026 | 78.5M |
| Q2 2026 | 77.5M |
| Q3 2026 | 76.6M |
Shares outstanding: 75.4M (2026-10-30)
Insider transactions
Form 4 open-market trades (codes S/P), trailing 12 months. Coverage: newest 50 of 74 filings; 50 filings parsed.
Sold by insiders
427.0K shares
$70.2M · 65 transactions
Bought by insiders
0 shares
0 transactions
Net direction
net selling